Sasha CucuzChief Executive Officer at Greybrook Securities Inc. & Partner, Greybrook Capital
Sasha Cucuz is responsible for co-managing Greybrook's operation and investment strategy and plays a significant role in growing Greybrook’s real estate investment portfolio comprised of over 70 residential development projects throughout North America with an estimated completion value of $15B. As Co-chair of Greybrook’s Investment and Project Advisory Committees, Sasha is part of the team responsible for approving new acquisitions and overseeing existing limited partnerships.
As former CEO of Greybrook Health, Sasha has been involved in several key transactions throughout the Greybrook portfolio and has led several key financings for portfolio companies including TearLab Inc. (NASDAQ: TEAR), and Greenbrook TMS (TSX: GTMS), a U.S-based listed company that owns and operates a network of depression treatment centers throughout America.
Sasha is a board member of Greenbrook TMS, NeuPath Health, Canada's largest provider of Chronic Pain services, the Greybrook Foundation and Blu Genes Foundation.